According to the report, the Global Nuclear Imaging Market is estimated to be USD 11.89 billion and predicted to rise to USD 18.19 billion with a CAGR of 8.87% from 2019 to 2024.
The Global Nuclear Imaging Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
The market is segmented by Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, and Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, and Others)), By Application (PET-(Cardiology, Oncology, Neurology, and Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, and Others)). Further, the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa.
The growth of the Global Nuclear Imaging Market is mainly driven by factors such as increasing utilization of SPECT and PET examination in radiopharmaceuticals, rise in cognizance for prompt diagnosis, increasing frequency of cardiac diseases, and improving healthcare infrastructure in developing markets. However, factors such as costly procedures & equipment, shortage of supplies, logistical difficulties, and saturation in the developed countries are hindering the growth of the market.
PET is mainly being utilized in oncology due to the superior quality of imaging; Whereas SPECT is used in the cardiology section accounting for almost 80% of the entire cardiology market share.
U.S accounted for the largest share in the global Nuclear Imaging market in 2015, as it spends nearly 20% of its GDP on health. However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as the growing geriatric populace and surge in the chronic disease population.
Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the global Nuclear Imaging market are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
Avail Sample Market Brochure of the report for more info @ https://www.marketdataforecast.com/market-reports/nuclear-imaging-market/request-sample
Browse Regional Reports: